AbbVie (NYSE:ABBV) Provides Earnings Guidance for Fiscal Year 22
On Friday, AbbVie (NYSE: ABBV) issued an updated version of its earnings guidance for the fiscal year 2022. In contrast to the general public’s expectations, …
On Friday, AbbVie (NYSE: ABBV) issued an updated version of its earnings guidance for the fiscal year 2022. In contrast to the general public’s expectations, …